A Real-World Study of EkoSonic Endovascular System in Chinese Populations With Acute Pulmonary Embolism

NCT06819865 · tracked via the Priya Life Science China tracker

Sponsor

Boston Scientific Corporation

Phase

Observational

Started

2026-08-30

Last updated

2026-08-17

Condition(s) studied

Acute Pulmonary Embolism

Investigational drug(s) / intervention(s)

EkoSonicTM Endovascular System

EkoSonicTM Endovascular System: EkoSonicTM Endovascular System and its upgraded versions if applicable The EkoSonicTM Endovascular System is a non-implanted system comprising a sterile, single-use EkoSonic Endovascular Device (Infusion Catheter and Ultrasonic Core) and reusable EKOSTM Control System 4.0(Control Unit, Connector Interface Cable and power cord).

Study summary

This study to collect the real-world clinical outcome data of EkoSonicTM Endovascular System in Chinese patients with acute pulmonary embolism during practical clinical care.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: 1. The patients with acute symptomatic pulmonary embolism (Symptomatic duration \< 14 days). 2. The right ventricle diameter to left ventricle diameter of end-diastolic dimension ratio ≥1 measured by echocardiographic image 3. Investigator has selected the EkoSonicTM Endovascular System with r-tPA to treat patient. Exclusion Criteria: 1. The patients with acute symptomatic pulmonary embolism (Symptomatic duration \< 14 days). 2. The right ventricle diameter to left ventricle diameter of end-diastolic dimension ratio ≥1 measured by echocardiographic image 3. Investigator has selected the EkoSonicTM Endovascular System with r-tPA to treat patient.

Primary outcome measure(s)

RV vs LV end-diastolic diameter ratio — after the completion of EKOS treatment 48 hours compared with the baseline
The change in the right ventricular end-diastolic diameter to left ventricle end-diastolic diameter ratio at 48hours after the completion of EKOS treatment compared with the baseline.

Trial sites (1)

Facility	City	Region	Status
The first Affiliated Hospital, Sun Yat-sen University	Guangzhou	Guangdong	Recruiting

More Boston Scientific Corporation trials in China

FARAPULSE™ Pulsed Field Ablation System Recruiting

IT Matters: The Erectile Restoration Registry Enrolling by invitation

Intra-operative Pancreatoscopy in Patients With IPMN Active, not recruiting

PVI Alone vs PVI and Linear Ablation for Persistent Atrial Fibrillation (PROMPT AF II) Recruiting

OverStitch NXT Endoscopic Suture System Recruiting

Other trials for the same condition

Saline Contrast Electrical Impedance Tomography Method for Diagnosis of Acute Pulmonary Embolism Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06819865 on ClinicalTrials.gov ↗ ← All trials in China